APA (7th ed.) Citation

Fang, H., Li, Y., Li, J., Sun, Y., & Zang, Y. (2026). Transcriptome profiling and experimental validation identify FOS, RAC2, and TYROBP as potential biomarkers for Fu's subcutaneous needling in neuropathic pain treatment. Molecular Pain, 22, 1. https://doi.org/10.1177/17448069261459255

Chicago Style (17th ed.) Citation

Fang, Huiqin, Yaping Li, Jiaqi Li, Yarong Sun, and Yunhua Zang. "Transcriptome Profiling and Experimental Validation Identify FOS, RAC2, and TYROBP as Potential Biomarkers for Fu's Subcutaneous Needling in Neuropathic Pain Treatment." Molecular Pain 22 (2026): 1. https://doi.org/10.1177/17448069261459255.

MLA (9th ed.) Citation

Fang, Huiqin, et al. "Transcriptome Profiling and Experimental Validation Identify FOS, RAC2, and TYROBP as Potential Biomarkers for Fu's Subcutaneous Needling in Neuropathic Pain Treatment." Molecular Pain, vol. 22, 2026, p. 1, https://doi.org/10.1177/17448069261459255.